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mTORUterine implantation is a critical element of mammalian reproduction and is a tightly and highly coordinated
event. An intricate and reciprocal uterine-embryo dialog exists to synchronize uterine receptivity with the
concomitant activation of the blastocyst, maximizing implantation success. While a number of pathways in-
volved in regulating uterine receptivity have been identiﬁed in the mouse, less is understood about blastocyst
activation, the process by which the trophectoderm (TE) receives extrinsic cues that initiate new character-
istics essential for implantation. Amino acids (AA) have been found to regulate blastocyst activation and TE
motility in vitro. In particular, we ﬁnd that arginine and leucine alone are necessary and sufﬁcient to induce
TE motility. Both arginine and leucine act individually and additively to propagate signals that are dependent
on the activity of the mammalian target of rapamycin complex 1 (mTORC1). The activities of the well-
established downstream targets of mTORC1, p70S6K and 4EBP, do not correlate with trophoblast motility,
suggesting that an independent-rapamycin-sensitive pathway operates to induce trophoblast motility, or
that other, parallel amino acid-dependent pathways are also involved. We ﬁnd that endogenous uterine fac-
tors act to induce mTORC1 activation and trophoblast motility at a speciﬁc time during pregnancy, and that
this uterine signal is later than the previously deﬁned signal that induces the attachment reaction. In vivoma-
tured blastocysts exhibit competence to respond to an 8-hour AA stimulus by activating mTOR and subse-
quently undergoing trophoblast outgrowth by the morning of day 4.5 of pregnancy, but not on day 3.5. By
the late afternoon of day 4.5, the embryos no longer require any exposure to AA to undergo trophoblast out-
growth in vitro, demonstrating the existence and timing of an equivalent in vivo signal. These results suggest
that there are two separate uterine signals regulating implantation, one that primes the embryo for the at-
tachment reaction and another that activates mTOR and initiates invasive behavior.
© 2011 Elsevier Inc. All rights reserved.Introduction
Successful uterine implantation is a critical element of mammalian
reproduction, without which the embryo cannot continue its devel-
opment. The process of implantation is a tightly and highly coordinat-
ed event that is systematically and systemically driven by changes in
the hypothalamic-pituitary-gonadal axis (Belchetz et al., 1978; Blissy, University of Virginia, 1300
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z), pmmartin@ncat.edu
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nch, National Human Genome
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rights reserved.et al., 2010; Levine and Ramirez, 1982; Levine et al., 1982; Midgley
and Jaffe, 1971; Santen and Bardin, 1973). Cyclic changes in the ovar-
ian derived hormones progesterone (P4) and estrogen (E2) not only
direct follicular maturation and ovulation, but signiﬁcantly, also
cause changes to uterine physiology that alter its normally non-
receptive state to a environment receptive to the conceptus (Chen
et al., 2000; Das et al., 1994b; Lubahn et al., 1993; Lydon et al.,
1995; Psychoyos, 1973a,b; Song et al., 2000; Tranguch et al., 2005;
Wang et al., 1994; Yoshinaga and Adams, 1966; Yoshinaga et al.,
1969). This receptive state lasts for a very short time during the estrus
cycle, and is thus deﬁned as a “window of receptivity”.
Concomitantly, but in an initially separate process, the mouse em-
bryo follows an intrinsic differentiation program. After fertilization
the zygote increases in cell number, initiates zygotic gene transcrip-
tion, and undergoes two integral morphogenetic events: blastomere
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and Johnson, 1980). As a result, the formerly spherical embryo be-
comes a blastocyst comprised of the inner cell mass and an encom-
passing layer of trophectoderm. The inner cell mass will give rise to
the embryo proper, while the trophectoderm will initiate implanta-
tion and give rise to the extraembryonic structures (Hillman et al.,
1972; Tarkowski and Wroblewska, 1967). Once formed, the blasto-
cyst will undergo a process of activation consisting of physiological
changes that enable it to attach to the uterine epithelium and invade
into the underlying stroma (Carson et al., 1993; Das et al., 1994b;
Hamatani et al., 2004; Paria et al., 1993b; Raab et al., 1996; Schultz
and Armant, 1995; Schultz et al., 1997; Wang et al., 2000; Xie et al.,
2008).
For implantation to occur properly, the change in uterine receptiv-
ity and the activation of the blastocyst must be very precisely coordi-
nated. To accomplish this, the embryo and uterus exist is in a state of
continuous crosstalk consisting of signals that regulate each other's
progress toward implantation. Disruption of this embryo-uterine dia-
log disrupts the process of implantation, diminishes fertility, and
causes adverse ripple effects on placentation and offspring viability
(Song et al., 2002; Wang et al., 2004, 2007; Wilcox et al., 1999; Ye
et al., 2005).
Uterine receptivity in the mouse is initiated by a surge of nidatory
E2 on the morning of implantation which induces changes in gene ex-
pression and, in particular, expression of the cytokine Leukemia In-
hibitory Factor (LIF) in the glandular epithelium (Bhatt et al., 1991;
Shen and Leder, 1992; Stewart et al., 1992). LIF is the key regulator
of receptivity downstream of E2 signals, and is sufﬁcient to trigger
implantation in the absence of an E2 surge (Chen et al., 2000). It is a
potent intercellular signaling molecule, with pleiotropic effects on
both uterine epithelium and stroma that are necessary for stromal
cell decidualization (Chen et al., 2000; Fouladi-Nashta et al., 2005),
as well as for regulating blastocyst activation and embryonic gene
and protein expression (Hamatani et al., 2004). The molecular path-
ways regulating uterine receptivity downstream of E2 and LIF have
begun to be elucidated, with the progesterone receptor (PR) and Indi-
an Hedgehog (Ihh) identiﬁed as key mediators of the receptivity re-
sponse both in the epithelium (Franco et al., 2010; Lee et al., 2006;
Wakitani et al., 2008) and in the stroma (Franco et al., 2011; Large
and Demayo, 2011; Lydon et al., 1995). The importance of LIF, IHH,
and PR to uterine receptivity and blastocyst activation is demonstrat-
ed by the ﬁndings that mice lacking any of these proteins are infertile
due to failure of blastocyst attachment and decidualization.
While progress has been made in understanding the regulation of
uterine receptivity, the process of blastocyst activation itself remains
poorly understood. Previous work indicates that amino acids (AA)
play an important role in blastocyst activation. Mouse embryos culti-
vated in vitro require a speciﬁc and deﬁned culture medium contain-
ing amino acids (Gwatkin, 1966; Naeslund, 1979; Spindle, 1980;
Spindle and Pedersen, 1973). This embryonic requirement for AA is
not simply nutritive, as AA exposure induces trophectoderm motility
through activation of mTOR-dependent signal transduction cascades
only after the embryo has reached the early blastocyst stage (Martin
and Sutherland, 2001; Martin et al., 2003). A short pulse (4–8 h) of
AA exposure is sufﬁcient to induce motility in the trophectoderm of
the early blastocyst, leading to trophoblast outgrowth in an in vitro
model of in vivo implantation behavior (Martin and Sutherland,
2001; Martin et al., 2003). The requirement for AA at this stage acts
as a developmental checkpoint; when cultured in vitro without AA
supplementation, blastocysts remain in a quiescent state, from
which trophoblast motility can be induced at any time by adding AA
to the culture medium. Once induced, the effect of AA is not revers-
ible, as removing AA will not then switch embryos back to a quiescent
state.
Through an as yet incompletely deﬁned mechanism, AA have long
been known to regulate the activity of mTOR (mammalian target ofrapamycin); a highly conserved serine/threonine protein kinase
which phosphorylates speciﬁc downstream effectors and in turn pro-
motes overall cellular growth via the translation of speciﬁc popula-
tions of mRNAs. mTOR is known to exist in two biochemically and
functionally distinct protein complexes: mTORC1 and mTORC2
(Hara et al., 2002; Kim et al., 2002; Sarbassov et al., 2004), which
have distinct downstream targets and cellular effects. mTORC1 sig-
naling is required for mouse embryo implantation (Gangloff et al.,
2004; Guertin et al., 2006), and has been implicated in AA regulation
of trophoblast motility (Martin and Sutherland, 2001). However, the
pathways linking amino acids to mTORC1 and then to motility have
not been identiﬁed. We show here that leucine and arginine, and in
particular, uptake of leucine through the SLC6A14 amino acid trans-
porter, are each required individually and together are sufﬁcient to
induce blastocyst activation. Importantly, leucine and arginine acti-
vate mTORC1 and are rapamycin-sensitive, both individually and in
combination, yet activate TE motility independently of the well-
characterized targets of mTORC1, p70S6K and 4EBP. Blastocyst activa-
tion in vivo is accompanied by changes in mTOR localization, and
these changes occur on day 4.5 of gestation, after the onset of embryo
attachment, suggesting that there are two separate signals from the
uterus regulating the phases of implantation.
Materials and methods
Materials
ICR male and female mice were obtained from Taconic. Embryo
culture medium (Martin and Sutherland, 2001; Spindle, 1980;
Stephens et al., 1995) was produced in house using embryo tested es-
sential amino acids, salts, bovine serum albumin (BSA), and mineral
oil purchased from Sigma Aldrich Chemicals (St. Louis, MO). Anti-
bodies used for detection of total and phosphorylated proteins via
western blots against phospho-p70S6K Thr389 (#9205), p70S6K
Total (#9202), phospho-4EBP 37/46 (#9459), and 4EBP total
(#9452) were purchased from Cell Signaling Technology (Boston,
MA). Phospho-4EBP Ser 65was produced by Dr. Thurl Harris (University
of Virginia). Antibodies used for protein expression and localization of
mTOR (#2972), Raptor (#24 C12), Rictor (#53A2), and LST8 (#86B8)
by western blot and immunoﬂuorescence were also purchased from
Cell Signaling Technology. The antibody used to detect protein levels of
SLC6A14 (#ab99102) via immunoblot was purchased from Abcam
(Cambridge, MA) and antibody to tubulin was from Sigma. Bovine ﬁbro-
nectin, cycloheximide, NO711, BCH, and DMSO were purchased from
Sigma, and rapamycin was from Calbiochem (San Diego, CA). The anti-
bodies used for mTOR immunoﬂuorescence were purchased from
Cell Signaling Technology (#2983) and Santa Cruz Biotechnology
(#SC-136269). The superovulatory hormone PMSG was purchased
fromCalBiochemandhCGwas fromSigma. [3H]Arginine and [3H]leucine
were purchased from Perkin Elmer (Waltham, MA).
Embryo culture
Embryos were ﬂushed at the 2-cell stage from superovulated and
mated female ICR mice and cultured from 48 to 120 h phCG as previ-
ously described (Martin and Sutherland, 2001; Sutherland et al.,
1993). 120 h phCG embryos were then transferred to 10 μl drops of
serum free medium supplemented with 4 mg/ml BSA and amino
acids and cultured for an additional 8–48 h depending on experimen-
tal design. After amino acid exposure embryos were subjected to a
trophoblast cell spreading assay. Medium containing a complete mix-
ture of amino acids will be designated +AA, and medium with no
amino acids−AA.−Arg,−Leu, or−Arg/−Leu refers to medium ex-
cluding only arginine and/or leucine individually while retaining all
other amino acids. +Arg, +Leu or +Arg/+Leu refers to medium
containing only 0.2 mM arginine and or leucine and no other amino
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imide (CHX 50 mg/ml) was used to inhibit protein translation, and
α-amanitin (10 mg/ml) was used to inhibit transcription. BCH and
NO711 were used at a concentration of 100 mM to inhibit SLC6A14
activity. All inhibitors were prepared from stock solutions in appro-
priate chemical vehicles (DMSO or water) and then diluted in medi-
um immediately prior to use.
Trophoblast cell spreading assay
Substrates of bovine ﬁbronectin were prepared as previously de-
scribed (Martin and Sutherland, 2001; Sutherlandet al., 1993). Embryos
were collected and cultured as described above and transferred to 10 μl
drops of medium overlaying ﬁbronectin coated plastic at designated
times and analyzed for trophoblast outgrowth at speciﬁc intervals. In
experiments using inhibitors (Rapa, CHX, α-amanitin, NO711, and
BCH) embryos were ﬁrst incubated for 1 h in −AA containing the
speciﬁc inhibitor and then transferred to medium with amino acids
and containing the same inhibitor. After 8 h the embryos were washed
three times in 550 μl of medium either containing or not containing
amino acids depending on experimental protocol, and then transferred
to ﬁbronectin coated drops of medium and analyzed for trophoblast
outgrowth at various intervals over the next 48 h (Sutherland et al.,
1993).
Western blotting
Oocytes and 2-cell, 8-cell, morulae, and blastocyst stage embryos
were collected over the course of several weeks and stored at –
80 °C until needed, then prepared for immunoblotting by lysing in
homogenization buffer (50 mM NaF, 1 mM EDTA, 1 mM EGTA,
1 mM DTT, 10 mM sodium phosphate, 50 mM β-glycerolphosphate
pH7.4, 1 mM PMSF, 10 μl/ml phosphatase inhibitor cocktail, 10 μg/ml
proteinase inhibitor cocktail, 10 μg/ml DNAse, 1%Tween-20). After
lysis, lysate equivalent to 100 oocytes or embryos was loaded per lane
of a 4–12% NuPage Novex Bis-Tris gradient gel (#NP0323), run and
then transferred to PVDF membrane (Milipore, Billerica, MA).
The membrane was blocked with 5% Non fat milk solution in TBS/T
(Blocking Buffer) for 1 h at room temperature, then incubated at 4 °C
overnight in buffer (1× TBS with 5%BSA, 0.01% Tween-20) containing
primary antibody. After washing, the blot was incubated with HRP-
conjugated donkey anti rabbit secondary antibodies in blocking buffer
(BioLegend, San Diego, MA) for 1 h at room temperature, washed
again and then chemiluminescence (Pierce, Rockford, IL) was used to
detect the proteins of interest; SLC6A14, p70S6K, 4EBP, mTOR, Rictor,
Raptor, Lst8 and tubulin, as well as phosphorylated forms of p70S6K
and 4EBP.
Uptake of [3H]Arginine and [3H]leucine
Embryos were cultured in various amino acid conditions for 8 h
from 120 to 128 h phCG. At 128 h phCG, embryos were transferred
to +AA medium containing [3H]arginine or [3H]leucine substituted
for non-radiolabeled arginine or leucine to the same concentration.
After 10 min incubation in [3H]AA medium, embryos were washed
three times in 550 μl of cold −AA, then placed into scintillation
vials and lysed with 100 μl boiling 2%SDS. Scintillation ﬂuid (Ready
Safe) was added, the vial was thoroughly vortexed, and the radioac-
tivity of the sample measured using a liquid scintillation counter
(Beckman LS1801). For inhibition experiments with BCH and
NO711, embryos were ﬁrst incubated with the inhibitor in−AA me-
dium for one hour at 120 h phCG and then transferred for 8 h into
amino acid containing medium from 121 to 129 h phCG followed by
a 10 minute pulse of [3H] amino acid pulse and liquid scintillation
detection as described above.Immunoﬂuorescence
Oocytes and embryos were ﬁxed in 3.7% formaldehyde in immuno-
ﬂuorescence (IF) buffer (40 mM PIPES pH 6.8, 200 mM NaCl, 2 mM
EGTA) for 15 min, washed three times in IF buffer for 5 min, permeabi-
lized with 0.1% Triton X-100/IF buffer for 2 min, washed three times in
IF buffer for 5 min and blocked in 1 hour at room temperature in Super
Block (5%BSA, 20%FBS). Oocytes or embryos were then incubated in
Super Block with primary antibody added (1:200) overnight at 4 °C.
The next day they were washed three times in 0.5% Tween20/IF Buffer
for 5 min and placed in 0.5% Tween20/IF Buffer solutionwith secondary
antibody added (Invitrogen, Carlsbad, CA) for 1 h at room temperature.
Lastly, oocytes and embryoswerewashed three times in 0.5% Tween20/
IF Buffer and 1× IF Buffer for 5 min,mounted in DAPI/PBS, and analyzed
by confocal and multiphoton microscopy.
Confocal microscopy and image analysis
The imaging system consisted of a Zeiss Axiovert 200M epiﬂuores-
cent motorized microscope with a 100 W Hg arc lamp and a halogen
lamp. A C-Apochromat 63× water NA 1.2 objective lens was used for
the studies described here. The Axiovert 200M was coupled to a
Zeiss510 confocal-multiphoton-spectral imaging system (www.
zeiss.de), and the system was controlled using the LSM software
(version 4.0). For confocal imaging, the system consisted of a 45 mW
argon laser (458, 488, 514 nm), a 10 mW (561 nm) laser and a
633 nm laser.We used 561 nm to excite the Alexa546 ﬂuorophore don-
key anti rabbit secondary antibody. For two-photon imaging a 10W
Verdi pumped, tunable (model 900Mira, www.coherentinc.com)mod-
elocked ultrafast (78 MHz) pulsed (b150 fs) laser was coupled to the
laser port of a Zeiss510 META/NLO. This laser was equipped with optics
for easy tunable range of the entire wavelength (700 to 1000 nm). The
system was equipped with spectrum analyzer (Model E201; www.
istcorp.com) to monitor the excitation wavelength. We used two-
photon 830 nm laser to excite the DAPI. Scanning confocal image stacks
were taken at 0.5 μm intervals. Confocal data was then analyzed using
Volocity (Improvision, Waltham, MA) to render three-dimensional re-
constructions and to capture images.
Uterine ﬂuid collection and spreading experiments
Uterine ﬂuid was collected using methods previously described
(Harris et al., 2005) from 8 to 10 mice per stage at 48, 60, 72, 120,
130, and 144 h phCG. The ﬂuid collected at each time point was
pooled together, spun down, and stored at −20 °C under oil until
just prior to use. In vitro matured 120 h phCG embryos were placed
in 5 μl drops of −AA medium on ﬁbronectin substrates, then the
−AA medium was removed and replaced with the warmed and
CO2-equilibrated uterine ﬂuid, and the embryos were then cultured
and analyzed at speciﬁc times for trophoblast outgrowth.
Statistical analysis
For experiments examining trophoblast outgrowth and amino acid
uptake, the data from a minimum of three experiments done in tripli-
cate were averaged and the standard deviation calculated. The averages
and standard deviations were analyzed for statistical signiﬁcance using
one-tailed ANOVA and the Student-Newman-Keuls test (Glantz, 1992).
Results
Arginine and leucine are necessary and sufﬁcient for blastocyst
activation and trophoblast outgrowth
Previous results have shown that amino acids are required at the
early blastocyst stage (120 h post-hCG for superovulated embryos,
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tion (Gwatkin, 1966; Martin and Sutherland, 2001; Martin et al.,
2003; Naeslund, 1979). Early results suggested that leucine and argi-
nine were particularly important for initiation of embryo outgrowth
(Gwatkin, 1966; Naeslund, 1979). Excluding either arginine or leu-
cine, or both, from the culture medium results in quiescent embryos
that fail to form outgrowths when placed on a ﬁbronectin substrate
(Fig. 1A) while exclusion of other individual AA does not affect tro-
phoblast motility. Notably, this includes glutamine, which in previous
work in cultured cells was found to be necessary for leucine uptake
(Nicklin et al., 2009). These data conﬁrm that the availability of argi-
nine and leucine alone are most critical to the initiation of in vitro tro-
phectoderm spreading.
Since arginine and leucine are required for trophoblast outgrowth,
we tested whether these amino acids were sufﬁcient to induce tro-
phectoderm spreading. An 8-hour pulse of either arginine or leucine
alone, at an optimal concentration of 0.2 mM, partially rescues
spreading (Fig. 1B). This effect is unique to either arginine- or
leucine-containing medium, as medium containing other individual
AAs fail to induce trophoblast outgrowth (Fig. 1B). Notably, the ef-
fects of arginine and leucine are additive. When embryos are stimu-
lated with 0.2 mM arginine and leucine in combination for 8 h, the
number of embryos exhibiting trophoblast outgrowth is signiﬁcantly
higher, while continuous combined exposure leads to a complete res-
cue of trophoblast outgrowth to control levels. In contrast to results
obtained in cultured cells (Nicklin et al., 2009), glutamine does not
synergize with leucine, and is inhibitory to arginine (Fig. 1B). Taken
together, these data show that arginine and leucine each contribute
individually to the induction of trophoblast outgrowth, and their ef-
fects are additive when in combination.
Leucine transport by the amino acid transporter SLC6A14 (ATB0,+) is
required for trophoblast outgrowth
Embryos take up and release amino acids via speciﬁc transporters.
Embryos express a large repertoire of transporters that vary in sub-
strate preference, and importantly, change according to embryonic
stage (Van Winkle, 2001; Van Winkle et al., 1985, 2006). Leucine
transport in particular, changes with the onset of the blastocyst
stage, becoming predominantly dependent on the SLC6A14 trans-
porter (also designated ATB0,+). SLC6A14 is a sodium-dependent,
neutral and cationic amino acid transporter with a broad speciﬁcity
but with a high afﬁnity for leucine, isoleucine, and methionine
(Borland and Tasca, 1974; Van Winkle et al., 1985, 2006).
The activity of SLC6A14 is likely regulated at the level of transcrip-
tion, as the message is not detected during preimplantation develop-
ment until the blastocyst stage (Martin et al., 2003; Van Winkle et al.,
1990a). Protein expression follows a similar pattern. Although 2-cell
embryos retain a robust amount of maternally inherited SLC6A14, it
is rapidly degraded by the 8-cell stage (Fig. 2A). Levels of SLC6A14
protein remain low at the morula stage but rapidly rise in theTable 1
Developmental stage of peri-implantation embryos and corresponding
hour post hCG (h phCG). Table summarizing the developmental stages
of in vitro matured mouse embryos normalized against second supero-
vulatory injection and expressed as hours post hCG (h phCG; hCG:
human chorionic gonadotropin).
Developmental stages Hours post hCG
2 Cell 48 h phCG
8 Cell 60 h phCG
Morulae 72 h phCG
Cavitating morulae 96 phCG
Early blastocyst 120 h phCG
Mid blastocyst 130 h phCG
Late blastocyst 154 h phCGblastocyst, coincident with the onset of SLC6A14 gene transcription,
and with the onset of competency to receive activation signals
(Martin and Sutherland, 2001). Exposing embryos to AA further in-
creases SLC6A14 expression, suggesting that its own translation
may be affected by mTOR activity (Fig. 2A).
To test whether leucine transport by SLC6A14 is central to tropho-
blast outgrowth, we used NO711, a non-substrate inhibitor of
SLC6A14 (Sloan, 2002), and BCH, a competitive inhibitor of leucine
transport that has been previously shown to inhibit leucine uptake
by SLC6A14 (Sloan and Mager, 1999). NO711 treatment blocked leu-
cine uptake (Fig. 2D) and trophoblast outgrowth both in the presence
of all AA and in the presence of leucine alone (Fig. 2B and Supplemen-
tal Fig. 1A). Embryos cultured in +Arg medium were unaffected by
the addition of NO711, consistent with the fact that arginine uptake
is predominantly through the Slc3a1/Slc7a9 (b0,+) heterodimeric
amino acid transporter (Van Winkle et al., 1990b). In +Leu/+Arg
medium NO711 reduced spreading to levels comparable to those in
medium containing arginine alone (Fig. 2B). Treatment of embryos
with BCH yielded similar results (Fig. 2B).
We examined the speciﬁc requirement for SLC6A14 transport in
two ways. First, we cultured embryos in medium containing NO711
and increasing levels of leucine, which resulted in greatly increased
uptake of leucine through other transporters, but no increase in tro-
phoblast outgrowth (Figs. 3A, B). Secondly, SLC6A14 also transports
methionine and isoleucine with similar Km/Ki to leucine (Sloan and
Mager, 1999; VanWinkle et al., 1985, 1988, 2006). However, embryos
cultured in medium containing arginine in combination with either
methionine or isoleucine show no additive effect on trophoblast out-
growth (Supplemental Fig. 1B). These data show that leucine trans-
port speciﬁcally via SLC6A14 is critical for stimulation of trophoblast
outgrowth as well as for the combined action of arginine and leucine
together.Glutamine blocks the effects of arginine on trophoblast outgrowth
Eliminating glutamine from embryo culture does not affect TGC
outgrowth, nor does medium solely containing glutamine induce
spreading (Figs. 1A, B). Interestingly, when embryos are cultured in
the presence of 0.2 mM arginine and 4.0 mM glutamine, arginine up-
take and trophoblast outgrowth is completely inhibited (Fig. 1B).
Conversely glutamine does not inhibit spreading either in complete
amino acid conditions or in medium containing a combination of leu-
cine and glutamine (Fig. 1B). Glutamine's negative effects are exclu-
sive to arginine, and may explain why embryos fail to spread when
leucine is individually excluded from the culture medium despite
the continued presence of arginine (Fig. 1A).Arginine and leucine rescue is rapamycin sensitive
We previously showed that AA induced trophoblast outgrowth is a
rapamycin sensitive event, and thus is upstreamof the serine/threonine
kinase complex mTORC1. Rapamycin is an immunophillic macrolide
that allosterically inhibits mTORC1 activity by speciﬁcally binding to
the protein mTOR when complexed with Raptor and LST8 in the
mTORC1 complex. Given that arginine and leucine are individually re-
quired for trophoblast outgrowth, we hypothesized that each had a
separate, required, action that together led to blastocyst activation,
and that one of these separate actions was mTOR activation. We tested
this hypothesis by culturing embryos inmedium containing either argi-
nine or leucine alone or both in combination, and adding rapamycin to
block mTORC1 activity. Rapamycin completely blocked trophoblast
outgrowth under all three conditions (Fig. 4A). Thus the effects of
both arginine and leucine are rapamycin-sensitive, implying that each
activates mTORC1.
Fig. 1. Arginine and leucine are necessary and sufﬁcient for trophoblast outgrowth. A. Graph showing the percent of embryos exhibiting any trophoblast outgrowth following 8 h of
culture in medium containing all amino acids except the indicated ones: arginine and/or leucine (−Arg, −Leu, −Arg−Leu); Isoleucine (− Iso), Threonine (−Thr), Histidine
(−His), Tyrosine, (−Tyr), Lysine (−Lys), Glutamine (−Gln). B. Graph showing the percent of embryos exhibiting any trophoblast outgrowth following 8 h of culture in medium
containing no amino acids except the indicated ones: 0.2 mM arginine (+Arg) or 0.2 mM leucine (+Leu) or both in combination (+Arg+Leu); Isoleucine (+Iso), Threonine
(+Thr), Histidine (+His), Tyrosine, (+Tyr), Lysine (+Lys), Glutamine (+Gln). For both graphs A and B, the data represent the mean+/−SEM for 6 independent experiments.
Mean values labeled with different letters are signiﬁcantly different from one another, p≤0.01.
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upon translation but independent of transcription
mTORC1 activates translation of speciﬁc populations of mRNAs,
including TOP RNA and cap dependent translation of mRNAs contain-
ing particularly complicated 5′ untranslated regions (De Benedetti
and Rhoads, 1990; Koromilas et al., 1992; Lazaris-Karatzas et al.,
1990). Induction of trophoblast outgrowth by +AA medium requires
translation (Martin and Sutherland, 2001), so we hypothesized that
the effect of arginine and/or leucine on trophoblast outgrowth is sim-
ilarly dependent upon translation. To test this, embryos were cul-
tured for 8 h in medium known to promote spreading (+AA, +Arg,
+Leu, and +Arg/Leu) and cycloheximide (CHX) was added at con-
centrations known to inhibit mRNA translation (Epstein and Smith,
1973). The presence of CHX inhibited trophoblast outgrowth in all ex-
perimental groups (Fig. 4B). These results indicate that the effect of
both arginine and leucine on trophoblast outgrowth requires protein
translation. We next tested whether transcription was necessary for
the induction of trophoblast spreading. Embryos were cultured for
8 h in medium known to promote spreading (+AA, +Arg, +Leu,
and +Arg/Leu) and α-amanitin was added at concentrations known
to inhibit mRNA transcription (Flach et al., 1982; Levey and Brinster,
1978; Lindell et al., 1970). The presence of α-amanitin did not affect
spreading, indicating that the effects of arginine and leucine are inde-
pendent of transcription during the 8 h of AA exposure (Fig. 4C).Phosphorylation of known downstream targets of mTORC1 fails to
correlate with embryo spreading
mTORC1's effects on translation are accomplished via the phos-
phorylation of two well established downstream effectors, p70S6K
and 4EBP. p70S6K and 4EBP both regulate protein translation (Lin et
al., 1994; Pause et al., 1994). Phosphorylation by mTORC1 at Thr389
activates p70S6K, which in turn phosphorylates ribosomal protein
S6, and may inﬂuence translation of TOP RNAs (De Benedetti and
Rhoads, 1990; Koromilas et al., 1992; Lazaris-Karatzas et al., 1990;
Shama and Meyuhas, 1996). Phosphorylation of 4EBP by mTORC1 re-
lieves its repression of eIF4E, and promotes cap dependant translation
by increasing the availability of eIF4E (Brunn et al., 1997; Pause et al.,
1994). We next sought to determine whether the phosphorylation
states of p70S6K and 4EBP correlated with embryo spreading. As
expected, embryos stimulated with +AA medium exhibited a strong
amount of p70S6K phosphorylation at Thr389, which is decreased in
embryos cultured in −AA medium or in +AA medium containing
rapamycin (Figs. 5A, C). Under all other culture conditions tested,
phosphorylation of p70S6K was low. Under conditions where tropho-
blast outgrowth is stimulated (+Arg, +Leu, and +Arg/+Leu)
p70S6K was phosphorylated to a similar degree as in −AA culture
conditions (Fig. 5C), while under conditions lacking leucine or both
arginine and leucine p70S6K was phosphorylated to an even lower
level (Figs. 5A, C). Surprisingly however, p70S6K phosphorylation
Fig. 2. SLC6A14 protein expression is temporally regulated and its activity is critical for trophoblast outgrowth. A. Western blot of whole cell lysates of 100 embryos at the indicated
stages, and of normal mouse lung as a control, probed with an antibody against SLC6A14 then probed with an antibody to tubulin as a loading control. (Mor: Morula, Blast:
Blastocyst). B. Graph showing the percent of embryos exhibiting any trophoblast outgrowth following 8 h incubation in the media indicated. The data in the ﬁrst three bars repre-
sent toxicity controls, where embryos were incubated for 8 h in +AA medium with or without NO711 or BCH, washed and then transferred to +AA medium on ﬁbronectin. All
other embryos were incubated for 8 h in medium containing the indicated amino acids, with or without NO711 or BCH, and then transferred into −AA medium on ﬁbronectin.
The data represent the mean+/−SEM of 6 independent experiments. Mean values labeled with different letters are signiﬁcantly different from one another (p≤0.01). C. Blastocyst
uptake of [3H]arginine and [3H]leucine following 8 h incubation in the indicated media. The number under each bar corresponds to the number on the list to the right of the graph
showing the medium used and the color of the bar represents the amino acid measured in that condition. The data represent the mean+/−SEM of 3 independent experiments
performed in triplicate. Mean values labeled with different letters are signiﬁcantly different from one another, (p≤0.01). D. Blastocyst up take of [3H]arginine and [3H]leucine fol-
lowing 8 h incubation in media containing the SLC6A14 inhibitors BCH or NO711. The letter under each bar corresponds to the letter on the list to the right of the graph indicating
the medium used and the color of the bar represents the amino acid measured in that condition. The data represent the mean+/−SEM of 3 independent experiments performed in
triplicate. Mean values labeled with different letters are signiﬁcantly different from one another (p≤0.01).
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where embryos did not spread at all (Figs. 5A, C).
mTORC1 phosphorylates 4EBP in a hierarchical fashion, ﬁrst at
Thr36/45 (Thr37/46 in mouse) and Thr69, and then at Ser64 (Ser65
in mouse) to fully relieve its association with eIF4E (Fadden et al.,
1997; Gingras et al., 1999; Mothe-Satney et al., 2000b), and phos-
phorylation of Thr69 and Ser64 are more sensitive to rapamycin
(Mothe-Satney et al., 2000a). 4EBP is phosphorylated both on
Thr37/46 and Ser65 in embryos cultured in +AA medium, andFig. 3. Increased leucine uptake via other amino acid transporters does not produce trophob
8 h incubation in medium containing increasing concentrations of leucine with or without N
in triplicate. Bars labeled with different letters are signiﬁcantly different from one another (
after 8 h of incubation in the indicated medium. For both graphs, the data represent the mea
with different letters are signiﬁcantly different from one another (p≤0.01).phosphorylation of both sites is decreased in embryos cultured in
−AAmedium or in+AAmedium containing rapamycin, with greater
decreases in phosphorylation seen for Ser65 in the presence of rapa-
mycin, as expected (Figs. 5A, B, C). Overall, though, the phosphoryla-
tion of 4EBP at both sites appears to be inversely correlated with the
ability of the embryo to initiate trophoblast outgrowth. Under condi-
tions where trophoblast outgrowth is partially rescued (+Arg, +Leu)
4EBP is only moderately phosphorylated both on Thr37/46 and Ser65,
with somewhat more robust phosphorylation in the +Arg/+Leulast outgrowth. A. Graph showing mean uptake of [3H]leucine by blastocysts following
O711. The data represent the mean+/−SEM of 3 independent experiments performed
p≤0.01). B. Graph showing percent of embryos exhibiting any trophoblast outgrowth
n+/−SEM of 3 independent experiments performed in triplicate. Mean values labeled
Fig. 4. mTOR activation and protein translation are necessary for arginine- or leucine-
stimulated trophoblast outgrowth, but RNA transcription is not. A. Graph showing
the percent of embryos exhibiting trophoblast outgrowth following 8 h incubation in
medium containing the indicated amino acids in combination with rapamycin
(Rapa). B. Graph showing the percent of embryos exhibiting trophoblast outgrowth
following 8 h incubation in medium containing the indicated amino acids in combina-
tion with cycloheximide (CHX). C. Graph showing the percent of embryos exhibiting
trophoblast outgrowth following 8 h incubation in medium containing the indicated
amino acids in combination with alpha-amanitin. For all graphs, the data represent
the mean+/−SEM from 4 independent experiments. Mean values labeled with differ-
ent letters are signiﬁcantly different from one another (p≤0.01).
Fig. 5. Phosphorylation of TORC1 downstream effectors p70S6K or 4EBP does not cor-
relate with embryo spreading. A. Western blot of whole-cell lysates of 100 embryos
(per lane) cultured for 8 h in the indicated medium, probed sequentially for
phospho-Thr389 p70S6K and phospho-Thr37/46 4EBP, then for the total amount of
p70S6K and 4EBP, and ﬁnally for tubulin as a loading control. B. Western blot of
whole-cell lysates of 100 embryos cultured for 8 h in the indicated medium, probed se-
quentially for phospho-Ser64 4EBP and for tubulin as a loading control. C. Graphical
representation of the percentage of p70S6K that is phosphorylated at Thr 389 and of
4EBP that is phosphorylated at Thr37/46 or Ser64, normalized to tubulin for each sam-
ple. These values are derived from quantitation of the blots shown in A and B, which
are consistent with other blots done on these same treatment groups.
Fig. 6. The TORC1 components mTOR and Raptor are preferentially expressed in the
blastocyst. Western blot of whole-cell lysates (WCL) of 100 embryos (per lane) at
the indicated stages, and of the rat choriocarcinoma cell line (Rcho-1) and the
human embryonic kidney cell line S293 (293S), probed simultaneously with antibodies
against mTOR, Rictor, Raptor, and LST8, and then probed with an antibody against tu-
bulin as a loading control. (Mor, Morula; Blast, Blastocysts).
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phorylated at both Thr37/46 and Ser65 in embryos cultured under
conditions where trophoblast outgrowth is inhibited (−Arg, −Leu
and −Arg/−Leu) (Figs. 5A, B, C). These data indicate that despite
the fact that arginine and/or leucine initiate a signal cascade that re-
quires both mTORC1 and protein translation in order to produce
changes in cell behavior and motility, the activities of the well estab-
lished downstream targets of mTORC1 that mediate its effects on
translation fail to correlate with the ability of the embryo to initiate
trophoblast outgrowth.
The amino acid sensitive mTORC1 components are preferentially
expressed in the mouse blastocyst
Since mTOR can form two functionally distinct complexes we next
examined the developmental proﬁle of the various protein compo-
nents of mTORC1 and mTORC2 to provide insight into the relevanceof these two complexes in relation to each other and with respect
to implantation. mTOR protein levels remain steady from oocyte to
blastocyst while Raptor protein levels speciﬁcally increase in morulae
and blastocysts (Fig. 6). Conversely, levels of the mTORC2-speciﬁc
subunit Rictor are relatively high in the oocyte and 2-cell embryo,
but diminished in the blastocyst (Fig. 6). Interestingly, protein ex-
pression of the common subunit LST8 also decreases in the blastocyst
(Fig. 6). It appears that mTOR and Raptor are preferentially expressed
in the implantation stage embryo while Rictor and LST8 are not. These
data are consistent with the results of mouse knockouts (Gangloff
et al., 2004; Guertin et al., 2006). Knockouts of mTOR and Raptor
are lethal at the peri-implantation stage, while knockouts of Rictor
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These ﬁndings suggest that mTOR and Raptor functions are most crit-
ical to the implanting embryo and that the embryonic rapamycin-
sensitive mTORC1 is unique in that it may operate or exist without
LST8.
mTOR localization changes throughout development and upon embryo
activation
Although mTOR protein levels remain steady from oocyte to blas-
tocyst, its cellular distribution changes substantially during this
period (Fig. 6). Oocytes and embryos at 48 and 68 h phCG (2-cell
and 8-cell respectively, Table 1) exhibit diffuse cytoplasmic localiza-
tion of mTOR. As the embryo reaches 72 h phCG (morula, Table 1)
mTOR localization begins to change from a diffuse distribution into
aggregates of perinuclear puncta (Fig. 7). The 120 h phCG embryo
(early blastocyst, Table 1) retains this change in localization with dis-
tinct perinuclear puncta and additional plasma membrane localiza-
tion (Fig. 7). Stimulation of embryos with medium containing all AA
results in a large increase in immunoﬂuorescent staining intensity
(Fig. 8B). Embryos cultured in +AA medium containing rapamycin
(+AA Rapa) show an intermediate phenotype, with a modest
amount of increased mTOR signal (Fig. 8C), as well as a loss of the
plasma membrane localization. The change in immunoﬂuorescent
signal intensity following AA exposure is antibody-speciﬁc, and is
consistently seen when using the rabbit monoclonal antibody 7C10
from Cell Signaling Technology. This antibody recognizes a region
of the protein at the C-terminus around the autophosphorylation
site at Ser2481, phosphorylation of which is the major indicator of
mTOR activation (Yang and Guan, 2007). We veriﬁed that the change
in ﬂuorescent intensity is not due to an overall change in protein ex-
pression in two ways. First we examined protein expression directly
by Western blot of whole cell lysate from embryos cultured in either
+AAor−AA, and found nodifference in protein levels (Fig. 8J). Second,
we performed double-label immunoﬂuorescence using the Cell Signal-
ing Technology anti-mTOR antibody and a mousemonoclonal antibody
from Santa Cruz Biotechnology (#sc-136269) that was raised against
amino acids 185–290 from the N-terminus of mTOR. The localization
of mTOR using the Santa Cruz antibody was similar to that seen with
the Cell Signaling antibody, but its staining intensity was similar in em-
bryos cultured in−AA and those cultured in+AA (Fig. S3). Collectively
these data suggest that the increase in ﬂuorescence seen when usingFig. 7.mTOR localization in oocytes and peri-implantation embryos. Immunoﬂuorescent loc
(8-cell), 96 h (morula), and 120 h phCG (blastocyst). The images are extended focus compthe Cell Signaling Technology antibody may be due either to a change
in conformation of mTOR, to phosphorylation of Ser2481, or to an
unmasking event following mTOR activation, any of which might
allow the antibody to more efﬁciently recognize its epitope.
Regardless of the underlying mechanism, the dramatic change in
mTOR signal underscores the effect of amino acids on mTORC1 activa-
tion, and also serves as a powerful tool to monitor the activation state
of mTOR directly in the embryo. Consistent with outgrowth data, em-
bryos cultured either in +Arg, +Leu, or +Arg+Leu medium exhib-
ited an activated pattern of mTOR immunostaining (Fig. 9). Embryos
cultured in −Leu, −Arg, or −Arg−Leu medium also all exhibited
an activated pattern of mTOR immunostaining (Fig. 9). This is consis-
tent with the Western blot data showing phosphorylation of mTORC1
target proteins, and conﬁrms that mTORC1 activity is necessary but
not sufﬁcient to induce blastocyst activation.
Embryos receive activation signals in vivo
Trophoblast outgrowth is an in vitro manifestation of the invasive
behavior that the trophoblast cells exhibit as they initiate implanta-
tion. Because the in vitro conditions under which embryos are cul-
tured are different than those that they encounter within the
uterus, we examined the dynamics of mTOR activation in embryos
developing within the uterus. Mice were superovulated and mated
as before, but the embryos were then ﬂushed from the uteri at 96,
120, and 130 h phCG (Table 1), cultured for 8 h in medium either con-
taining AA or not, and then transferred to a ﬁbronectin substrate in
medium lacking AA to assay the induction of trophoblast outgrowth.
Embryos ﬂushed at 96 h phCG embryos did not form outgrowths
after 8 h culture in either medium, indicating that at this stage the
embryo is not yet competent to become activated, and also has not
yet been activated in vivo (Fig. 10A). Embryos ﬂushed at 120 h post-
hCG did spread following culture in +AA medium, but did not
when cultured in −AA medium (Fig. 10A). Moreover mTOR staining
of embryos ﬂushed at 120 h phCG resembled that of in vitro cultured
morulae and blastocysts prior to AA exposure (Figs. 10B, C). In con-
trast, embryos ﬂushed at 130 h phCGwere able to spread after culture
either with or without AA, and mTOR staining of these embryos re-
sembled that of in vitro cultured embryos following exposure to AA,
when mTOR has been activated (Figs. 10A, B, E). These data indicate
that in vivo, the embryo becomes competent by 120 h phCG to re-
spond to environmental conditions by activating mTOR, and further,alization of mTOR and DAPI within the oocyte, and in embryos at 48 h (2-cell) and 68 h
osites of confocal Z-stacks. Control is secondary antibody alone with DAPI staining.
Fig. 8. Immunoﬂuorescent signal intensity from Cell Signaling Technology (CST) antibody #2983 increases upon amino acid-stimulated mTOR activation. A. Unstimulated (−AA,
8 h) 120 h phCG blastocyst. B. Amino acid stimulated (+AA, 8 h) 120 h phCG blastocyst. C. Amino acid and Rapamycin (+AA/Rapamycin, 8 h) treated 120 h phCG blastocyst.
D. Increased mTOR signal intensity in 120 h phCG embryo stimulated with amino acids for 1′. E. Increased mTOR signal intensity in 120 h phCG embryo stimulated with amino
acids for 5′. F. Increased mTOR signal intensity in 120 h phCG embryo stimulated with amino acids for 10′. G. Unstimulated (−AA, 8 h) 120 h phCG blastocyst stained with antibody
to Raptor. H. Amino acid stimulated (+AA, 8 h) 120 h phCG blastocyst stained with antibody to Raptor. I. Secondary antibody alone control with DAPI staining. J. Western blot
showing the protein levels of mTOR and Raptor in stimulated and unstimulated embryos (+AA and −AA; 100 embryos per lane).
Fig. 9. Activated mTOR localization assessed by Cell Signaling Technology (CST) antibody #2983 in embryos cultured in various arginine and leucine containing media. Increased
mTOR signal intensity indicative of an activated mTORC1 in blastocysts after amino acid stimulation in the indicated media. Control is unstimulated blastocyst (−AA, 8 h) stained
for mTOR and DAPI.
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Fig. 10. In vivo embryos receive an activation signal between 120 h and 130 h phCG. A. Graph showing the percent of embryos ﬂushed from the uterus at 96 h, 120 h, or 130 h phCG
that form trophoblast outgrowths following culture in either +AA or−AA medium in vitro. (N=32 embryos 96 h phCG +AA; N=29 embryos 96 h phCG−AA; N=37 embryos
120 h phCG +AA; N=30 embryos 120 h phCG−AA; N=35 embryos 130 h phCG +AA; N=30 embryos 130 h phCG−AA). B. Graph showing the percent of blastocysts ﬂushed
from the uterus at either 120 h or 130 h phCG that exhibit localization of mTOR in a pattern characteristic of either the inactivated or activated state. (N=9 embryos 120 h phCG;
N=15 embryos 130 h phCG). C. mTOR immunoﬂuorescence of blastocyst ﬂushed from the uterus at 120 h phCG. D. mTOR immunoﬂuorescence in a blastocyst ﬂushed from the
uterus at 130 h phCG, characteristic of the inactivated mTOR signal intensity. E. mTOR immunoﬂuorescence in a blastocyst ﬂushed from the uterus at 130 h phCG, characteristic
of the activated mTOR signal intensity. F. Secondary antibody alone with DAPI staining.
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occur in the uterine milieu that provide the blastocyst with signals
that lead to mTOR activation and induction of trophoblast motility.
In vitro derived blastocysts can be activated by uterine ﬂuid isolated at
130 h phCG
To verify that uterine ﬂuid became competent to activate tropho-
blast motility by 130 h phCG, we collected uterine ﬂuid from mice at
various stages of pregnancy: 48, 60, 96, 120, 130, 142, 154 h phCG,
and then used it to stimulate in vitro matured 120 h phCG embryos
(early blastocysts), the peri-implantation stage known to be compe-
tent to receive activation signals. Embryos cultured in uterine ﬂuid
isolated 48–120 h phCG fail to become activated, and exhibit no
spreading on ﬁbronectin substrates (Fig. 11). However, uterine ﬂuid
isolated at 130 h phCG was able to promote trophoblast outgrowth,Fig. 11. 130 h phCG uterine ﬂuid stimulates trophoblast outgrowth. Graph showing the
percent of embryos exhibiting any trophoblast outgrowth following 24 h of culture in
uterine ﬂuid collected from mice at the indicated stages of pregnancy. Embryos were
ﬂushed at 48 h phCG, cultured in vitro to the blastocyst stage, and used in trophoblast
spreading assays when they were at 120 h phCG. Data represent the mean+/−SEM of
3 independent experiments. N=45 embryos per treatment.indicating that it contained in vivo derived elements capable of acti-
vating 120 h phCG embryos (Fig. 11). Interestingly, ﬂuid collected at
144 h phCG was not able to induce trophoblast outgrowth. These re-
sults conﬁrm that the uterine environment changes very speciﬁcally
between 120 and 130 h phCG to provide a signal to the embryo stim-
ulating the onset of trophoblast motility.
Discussion
Implantation is a central event in mammalian reproduction and is
therefore a tightly regulated and coordinated event. Two indepen-
dent but concomitant events, uterine receptivity and embryonic de-
velopment, must be synchronized in order to ensure efﬁcient
implantation, and thus achieve maximal reproductive success. To en-
able this synchronization, an intricate language has evolved allowing
the embryo and the uterus to be in constant communication. The na-
ture of the signals underlying this communication is not well under-
stood, but both previous work and the results presented here
demonstrate that amino acid activation of mTORC1 is an important
aspect of blastocyst activation, in particular for induction of motile,
invasive behavior in the trophectoderm (Martin and Sutherland,
2001; Martin et al., 2003).
In this paper we demonstrate that of all the amino acids tested,
only arginine and leucine are absolutely required for blastocyst acti-
vation. When either arginine or leucine, or both, are excluded from
the culture medium, trophoblast outgrowth on ﬁbronectin, a behav-
ior indicative of blastocyst activation, is completely inhibited. In addi-
tion, arginine and leucine together are also completely sufﬁcient to
induce trophoblast outgrowth. Individually, either arginine or leucine
partially induces blastocyst activation, and together they act additive-
ly to fully induce embryo activation. Interestingly, very similar results
have been described for ovine conceptuses, where leucine and argi-
nine, but not glutamine, are able to promote proliferation and tropho-
blast motility (Kim et al., 2011). Our ﬁndings differ somewhat from
those reported by Van Winkle et al. who found that arginine pro-
duced only a small amount of activation (Van Winkle et al., 2006).
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acid concentration (0.2 mM here vs 0.01 mM in that study), and per-
haps to differences in the embryonic state of development. While we
used in vitromatured blastocysts cultured from 40 h post-hCG in a sim-
ple deﬁned medium, Van Winkle et al. used in vivo matured, delay of
implantation embryos on day 8 of pregnancy, whichmay have been ex-
posed to uterine factors that could change their behavior.
Our results conﬁrm early observations that the mouse embryo re-
quires arginine and leucine (Gwatkin, 1966; Martin and Sutherland,
2001; Naeslund, 1979), but importantly they dissect out the purpose,
parameters, and proteins central to this requirement. Our results
suggest that arginine and leucine have overlapping functions in stim-
ulating trophoblast motility as demonstrated by their mutual require-
ment for mTORC1 activity for trophoblast outgrowth. However, we
also demonstrate that arginine and leucine have independent, non-
overlapping functions that are additive in stimulating blastocyst acti-
vation. It is possible that this ‘two key lock’ opened by arginine and
leucine serves either as a dual developmental checkpoint or else as
a ﬁne-tuning mechanism for the onset of implantation.
Embryos express a repertoire of amino acid transporters that can
change according to developmental stage. SLC6A14 is a Na+/Cl− de-
pendant transporter capable of forming AA gradients (Borland and
Tasca, 1974; Van Winkle et al., 1985, 2006). Protein expression of
SLC6A14 is speciﬁcally upregulated at the blastocyst stage, coincident
with the onset of competence to receive an extrinsic activation signal,
and further increases upon AA exposure. SLC6A14 plays an important
role in blastocyst activation. It is the major transporter for leucine in
the blastocyst (Van Winkle et al., 1990a), and signiﬁcantly, leucine
in particular must be transported via SLC6A14 to contribute to em-
bryo spreading. Inhibiting leucine uptake through SLC6A14 by treat-
ment with either NO711 or BCH leads to inhibition of trophoblast
outgrowth, which cannot be rescued by increased leucine uptake
through other transporters. Other high-afﬁnity substrates for
SLC6A14 such as isoleucine or methionine (Sloan and Mager, 1999;
Van Winkle et al., 1985, 1988, 2006) cannot substitute for leucine, in-
dicating that there is a role both for the amino acid and for the action
of the transporter. Since SLC6A14 is an active transporter, it can both
concentrate amino acids within the cell and can simultaneously create
a charge gradient by co-transport of 2 Na+ and 1 Cl− ion (Sloan and
Mager, 1999). The concentrative effect was hypothesized to be impor-
tant in stimulating uptake of arginine through SLC3A1/SLC7A9, a het-
erodimeric transporter which functions as a tightly coupled amino
acid antiporter (Martin et al., 2003; Palacin et al., 2005; Van Winkle,
2001). Our results, however, do not support this hypothesis, as arginine
uptake is not stimulated by addition of leucine, nor is it inhibited either
when leucine is not present in the medium or when leucine uptake
through SLC6A14 is inhibited. Furthermore, the concentration of leu-
cine within the cell does not appear to be the limiting factor, since up-
take of leucine at normal levels through other transporters is not
sufﬁcient to induce trophoblast outgrowth. This suggests that either
the changes in intracellular concentration of Na or Cl, or any resulting
changes to the membrane potential may synergize with the intracellu-
lar effects of leucine to induce blastocyst activation.
The timely expression of SLC6A14 at the blastocyst stage serves as
a key regulator of blastocyst activation, bestowing upon the 120 h
phCG embryo the ability to receive an activation signal both in vitro
and in vivo. In addition to the embryo's temporal regulation of
SLC6A14, factors related to the onset of uterine receptivity may also
act to regulate its activity in the embryo. For example, a global change
in the concentration of leucine in the uterine milieu could drive up-
take and subsequent embryo activation. Alternatively, concentrations
of Na+ in the uterus have been found to increase prior to implanta-
tion (Nilsson and Ljung, 1985; Van Winkle et al., 1983) and since
SLC6A14 is a Na+ dependant transporter, an overall increase in Na+
concentration could directly affect transport activity. Such an idea is fur-
ther supported by the ﬁnding that blastocysts do not form outgrowthswhenNa+ levels are reduced in culture conditions but become activat-
ed with increased Na+ concentration (Van Winkle, 1981). These and
other scenarios are equally plausible. Determination of uterine ﬂuid
composition at various hours phCG is needed to address this point
and future work will address these possibilities.
It is well documented that AAs, in particular arginine and leucine,
activate the serine/threonine protein kinase mTOR. mTOR can form
two biochemically and functionally distinct complexes, the tradition-
ally rapamycin sensitive mTORC1 and insensitive mTORC2. While
levels of the mTORC2 subunit Rictor are almost undetectable in the
blastocyst, the mTORC1 core component Raptor is preferentially
expressed at this stage. Interestingly, levels of the common compo-
nent LST8 decrease from oocyte throughout early preimplantation
stages, and are nearly undetectable in the blastocyst. The expression
data support the predominant role for mTORC1 in implantation
established in mouse knockouts for mTOR, Rictor, Raptor, and LST8
(Gangloff et al., 2004; Guertin et al., 2006). Somewhat different results
have been described for ovine embryos, where arginine treatment
leads to increased Akt1 phosphorylation, suggestive of mTORC2 activa-
tion (Kim et al., 2011).
In the presence of rapamycin, +AA medium fails to stimulate tro-
phoblast outgrowth, implicating mTORC1 activity in regulating this
behavior (Gangloff et al., 2004 ; Martin and Sutherland, 2001). Like-
wise embryos cultured in +Arg, +Leu, or+Arg+Leu medium in
the presence of rapamycin, fail to exhibit trophoblast outgrowth,
placing arginine and leucine, both individually and in combination,
upstream of mTORC1 in the pathway inducing trophoblast motility.
A major function of mTORC1 is to regulate cellular growth by phos-
phorylation of two downstream effectors, p70S6K and 4EBP, which
in turn increase the translation of speciﬁc populations of mRNAs
(De Benedetti and Rhoads, 1990; Koromilas et al., 1992; Lazaris-
Karatzas et al., 1990; Lin et al., 1994; Pause et al., 1994; Shama and
Meyuhas, 1996). The effects of either +Arg or +Leu medium on tro-
phoblast motility require protein translation but not mRNA transcrip-
tion during the 8-hour pulse of amino acid treatment. These
observations suggest that novel proteins are required to promote
the changes in trophectoderm cell motility required for implantation,
but that these proteins are unlikely to be transcription factors that in-
duce new gene expression.
Surprisingly, despite the clear requirement for mTORC1 activity and
new translation, trophoblast outgrowth was not correlated with the ac-
tivity of either p70S6K or 4EBP, asmeasured by their level of phosphor-
ylation by mTORC1. While only moderate levels of phosphorylation of
p70S6K and 4EBP were seen in embryos cultured under conditions
that promote trophoblast outgrowth (+Arg, +Leu, +Arg+Leu), we
detected robust amounts of phosphorylation of both proteins in embry-
os cultured under conditions where trophoblast outgrowth is inhibited
(−Arg,−Leu,−Arg−Leu). These observations suggest the presence of
novel rapamycin-sensitive actions of mTORC1 independent of both
p70S6K and 4EBP1. This possibility seems quite plausible given that
mTOR affects a wide variety of signaling pathways and cellular process-
es (Barbet et al., 1996; Di Como and Arndt, 1996; Kunz et al., 1993;
Laplante and Sabatini, 2009a,b). Alternatively, a rapamycin-sensitive
mTOR complex lacking LST8 (mTORC3?) might have alternative down-
stream targets in the blastocyst (Fig. 12). Only low levels of LST8 are
detected in the blastocyst, and embryos lacking LST8 do implant
(Guertin et al., 2006).
mTORC1 has also been shown to play a central role in skeletal
myogenesis, independent of kinase activity and the function of
p70S6K and 4EBP (Erbay and Chen, 2001). In this system mTOR reg-
ulates expression of IGF-II through both transcriptional and post-
transcriptional mechanisms (Erbay et al., 2003; Ge et al., 2011). IGF-II
is an interesting candidate as a potential regulator of trophoblast
differentiation in that it is preferentially expressed in TE cells at the
time of implantation (Lee et al., 1990), and is known to promote tropho-
blast cell differentiation (Kanai-Azuma et al., 1993). However, the
Fig. 12. Model for the action of amino acids on trophoblast cells at the time of implantation.
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from those deﬁned duringmyogenesis, given that de novo transcription
is not necessary for trophoblast outgrowth.
Although mTORC1 has primarily been studied in relation to its ef-
fects on cellular growth and proliferation, effects on motility are not
entirely unprecedented. Activation of mTORC1 speciﬁcally in kerati-
nocytes leads to accelerated wound healing both in vitro and in vivo
(Squarize et al., 2010) although the precise nature of the pathways
responsible for this behavioral transformation remain elusive. Actin
cytoskeletal dynamics are likely involved in the observed changes in
trophoblast cell motility, and althoughmTORC2 activity is traditional-
ly thought to affect the cytoskeleton, it remains equally plausible that
mTORC1 may also exert signiﬁcant effects on actin dynamics. Not
only does mTORC1 interact with Rho GTPases, such as P-Rex1,
(Hernandez-Negrete et al., 2007) it also plays a role in the progres-
sion and metastasis of colorectal cancer through RhoA and Rac1 acti-
vation (Gulhati et al., 2011). Given the similar cell behaviors during
the epithelial to mesenchymal transition that underlies both metasta-
sis and implantation, it seems possible that activated embryonic
mTORC1 may act in analogous manner to drive trophoblast motility.
While our results provide strong evidence that an activated, rapa-
mycin sensitive mTOR complex is necessary for blastocyst activation,
they also indicate that an activated mTOR complex is not sufﬁcient.
While mTOR is active in embryos cultured in−Arg or−Leu medium
as assessed both by increased p70S6K and 4EBP phosphorylation and
by immunostaining of mTOR (Figs. 5, 9), these embryos remain un-
able to form trophoblast outgrowths. This suggests that while argi-
nine and leucine activate a rapamycin sensitive mTOR complex that
in turn activates translation, these two amino acids also have inde-
pendent effects either downstream of or parallel to mTOR signals
(Fig. 12). Studies of ovine embryo development suggest a role for
polyamines and nitric oxide downstream of arginine (Kim et al.,
2011). Expression of ornithine decarboxylase, a rate-limiting enzyme
in the production of polyamines from arginine, is highly associated
with implantation in the mouse although inhibition by either chemi-
cal (Zhao et al., 2008) or genetic (Pendeville et al., 2001) approaches
does not prevent implantation. IGF-II induces production of thearginine derived bioactive molecule nitric oxide (NO) (Kaliman
et al., 1999; Lee et al., 1990) which can promote cell motility by mod-
ifying cell substrate adhesion (Brown et al., 2001; Chang et al., 2002;
Kaur et al., 1998; Liu et al., 2006). Importantly, disruption of NO sig-
naling inhibits formation of mouse blastocyst trophoblast outgrowths
(Sengoku et al., 2001). Clearly, further characterization of arginine-
and leucine-speciﬁc signals will be important to clarify the pathways
regulating motility.
mTOR protein levels remain steady throughout preimplantation
development, but its intracellular localization changes, which may re-
ﬂect its functional status. Studies in cultured cell models have shown
that amino acids promote activation of Rag GTPases and the trimeric
Ragulator complex, which in turn localize mTOR to the surface of
lysosomes where it can interact with its activator, Rheb GTPase
(Flinn et al., 2010; Sancak et al., 2008, 2010). Through the 8-cell
stage, embryos exhibit a diffuse cytoplasmic staining while morulae
and blastocysts show an increasingly punctate perinuclear and plas-
ma membrane-associated pattern. Embryos treated with +AA
showed a substantial increase in mTOR signal despite no change in
total mTOR protein expression, suggesting that amino acid signals
lead either to a change in mTOR conformation, or to a change in associ-
ation with other proteins that mask the antigenic epitope. In contrast,
no appreciable change in Raptor signal intensity was observed. Rapa-
mycin treatment does abrogate the increase in mTOR signal, although
there is amodest signal boost. The change inmTOR immunoﬂuorescent
signal occurs very rapidly, within even 1′ of+AA exposure, and re-
mains elevated in embryos subsequently transferred to−AA medium
(data not shown). The change in mTOR immunoﬂuorescent intensity
provides a very powerful tool formonitoring its activation state in intact
embryos, and strongly supports the concept that mTOR activation is a
checkpoint in blastocyst progression to the activated state. Embryos
cultured in −AA medium in vitro remain in a quiescent, non-
spreading state, but can be induced to spread with exposure to AA at
any time after 120 h phCG (Martin and Sutherland, 2001). The exposure
to AA is an irreversible signal after 4–8 h, as transfer back to−AA me-
dium does not inhibit the ability of the embryo to initiate trophoblast
outgrowth (Martin and Sutherland, 2001). Importantly, the difference
298 I.M. González et al. / Developmental Biology 361 (2012) 286–300in timing between mTOR activation (≤1 min) and the irreversible in-
duction of trophoblast outgrowth (4–8 h) also underscores our conclu-
sion thatmTORactivation is necessary but not sufﬁcient for this process.
The mTOR activation checkpoint seen in vitro also occurs in vivo,
and exhibits identical temporal dynamics. Embryos matured in vivo
to 96 h phCG were unable to form trophoblast outgrowths following
an 8-hour incubation in +AA, similar to in vitro matured embryos
(Martin and Sutherland, 2001). Embryos matured in vivo to 120 h
phCG exhibited a non-activated pattern of mTOR localization and
did not spread in the absence of exogenously supplied AA, but did
form trophoblast outgrowths when cultured in +AA medium, again
similar to those matured in vitro. This indicates that although the em-
bryos are competent to receive an activation signal at 120 h phCG, it
has not yet occurred in vivo. Conversely, by 130 h phCG embryos
not only exhibited increased mTOR signal intensity but spread in
both +AA and −AA medium, indicating that an activation signal
has occurred in vivo by this time. These results reveal the in vivo time-
line of embryo activation and provide evidence for a speciﬁc change
in the uterine milieu that is important for blastocyst activation. Fur-
ther evidence supporting a speciﬁc, temporally regulated change in
the uterine milieu was obtained by isolating uterine ﬂuid from mice
at the same stages of pregnancy. While uterine ﬂuid from mice at
48–72 h phCG not only failed to produce trophoblast outgrowth, it
also caused the embryos to bleb and appeared apoptotic. While
ﬂuid from 120 h phCG uteri was not toxic to blastocysts it did not
stimulate trophoblast outgrowth. Signiﬁcantly, uterine ﬂuid from
mice at 130 h phCG promoted trophoblast outgrowth by nearly all
blastocysts, but uterine ﬂuid from mice at 144 h phCG was not able
to induce trophoblast outgrowth. Thus, as embryos progress from
morning to evening on E4.5, uterine changes occur within a narrow
window of time that induce mTOR activation and the onset of tropho-
blast motility in preparation for the initiation of invasion. These uter-
ine changes could include modiﬁcation either in amino acid
composition, or in the concentration of NaCl, which could in turn
drive increased amino acid uptake. The timing of these changes sug-
gests that they could be a downstream effect of LIF action on the
decidualizing stroma and/or on the uterine epithelium (Ramathal
et al., 2010). Alternatively, interaction of the embryo with uterine-
derived soluble signals, such as Wnt4 (Franco et al., 2011) or with
HB-EGF on the uterine epithelium (Das et al., 1994a) may lead to in-
tracellular signals regulating the localization or activity of SLC6A14. In
particular, HG-EGF has been shown to induce calcium inﬂux leading
to accelerated trophoblast differentiation (Wang et al., 2000), and
the SLC6A14 transporter has two consensus sites for phosphorylation
by Protein Kinase C (PKC) and one for phosphorylation by CamKII
which may affect its function (Sloan and Mager, 1999). In this way,
attachment of the embryo to the uterine epithelium could conceiv-
ably facilitate transduction of the signal to initiate invasion.
Our data suggest that activation of trophoblast motility is inde-
pendent of the process of apposition and attachment. Previous stud-
ies have identiﬁed a uterine signal required for initiation of
apposition and attachment of the embryos to the uterine epithelium,
which occurs in the late afternoon of E3.5, and leads to the onset of
attachment by midnight of that evening (E4.0) (Das et al., 1994b;
Paria et al., 1993a; Song et al., 2000). In vitro, blastocysts exhibit in-
creased integrin trafﬁcking to the plasma membrane and subsequent-
ly acquire the ability to become adhesive as exhibited by binding to
ﬁbronectin beads (Schultz and Armant, 1995; Schultz et al., 1997;
Wang et al., 2002; Yelian et al., 1995). These changes in integrin dis-
tribution and ﬁbronectin binding occur even in the absence of an AA
signal (Martin and Sutherland, 2001), illustrating that the lack of tro-
phoblast spreading in−AA conditions does not arise from an inability
to become adhesive, but rather from an inability to initiate motility.
Consistent with the in vitro results, we show here that the onset of
motility is not induced in vivo until at least 10 h after the onset of at-
tachment, suggesting a two-step process by which the uterus signalsto the embryo to promote implantation. Our results suggest that the
second signal may result in changes in uptake of amino acids by the
embryos, particularly of leucine and arginine, which in turn both ac-
tivate mTORC1 and act independently and additively to induce tro-
phoblast motility.
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